Startups Are All Set To Showcase Their Groundbreaking Innovations At Startup Mahakumbh Biotech Pavilion

The biotech pavilion will be among the over 10 pavilions at Startup Mahakumbh, which will be held from March 18-20 in New Delhi, and will provide the startups from the sector an opportunity to showcase their innovations and connect with leaders and experts from the field.

Startup Mahakumbh is being organised by industry bodies ASSOCHAM, Nasscom, Bootstrap Incubation & Advisory Foundation, TiE, and the Indian Venture and Alternate Capital Association (IVCA) to bring together the entire Indian startup ecosystem, including startups, VCs, angel investors, family offices, HNIs, and potential corporate partners.

The three-day event will host 2K+ startups, 50+ unicorns, 10+ thematic pavilions, 1K+ investors, 300+ incubators and accelerators, 3K+ conference delegates, 10+ country delegations, and 50K+ business visitors. 

The biotech pavilion at the event will be led by Taslimarif Saiyed, director and CEO of C-Camp.

Expressing excitement about the potential impact which the pavilion can create, Saiyed said, “The biotech pavilion at Startup Mahakumbh will serve as a catalyst for innovation and collaboration within the biotechnology sector. We are thrilled to provide startups with a platform to showcase their innovations, connect with industry experts and access the resources they need to succeed.”

Opportunities Tailored To The Needs Of Biotech Startups

The pavilion aims to foster innovation and enable collaboration within the biotechnology sector. Distinguished keynote speakers from the industry will share their insights, providing a holistic view of the current landscape and future trends. Interactive discussions and workshops led by seasoned experts in the biotech and healthtech domains will offer learning experiences for attendees.

The speakers and mentors include BIRAC MD Dr Jitendra Kumar, Strand Lifesciences cofounder Dr Vijay Chandru, String Bio CEO and cofounder Dr Ezhil Subbian, Lakshmikumaran and Sridharan Attorneys executive director Dr Malathi Lakshmikumaran, and more. 

Biotech startups aiming to scale globally will learn national and international market outreach strategies in the specialised go-to-market strategies session. 

The pavilion will also feature personalised mentoring sessions on intellectual property rights and legal advisory, providing startups with crucial guidance on protecting their innovations and navigating legal challenges. In addition, investors from the biotech and pharma sectors will engage in reverse pitches, offering valuable insights and potential funding opportunities to participating startups. Finally, the pavilion will provide networking opportunities with industry leaders, heads of R&D Labs, investors, and fellow startups. 

“Indian pharma is working towards unleashing the expertise of India and building innovations for India and the world. New opportunities are coming up in diagnostics, digitally-enabled health solutions and biotech manufacturing. Innovation capacity must be built, eyeing India-specific and global problems and competing with the world,” Saiyed said on the potential of the biotech sector. 

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.